HIL Applied Medical Ltd.

hilappliedmedical.com

High-Tech Company

Ceased to Operate Q4/2023

Graduated from: Maayan Ventures

TECH VERTICALS

Cancer, Healthtech, Life Sciences, Medical Devices, MedTech, Nanotechnology, Radiation Therapy

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2010
Number of Employees	25
Reg. Number:	abCDe

DESCRIPTION

HIL Applied Medical is developing a new class of compact, high-performance cancer proton-therapy systems. HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with Nobel-Prize-winning ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility.

TECHNOLOGY

HIL applies a novel approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers (Nobel Prize in Physics 2018) and ultra-fast magnets. These technologies enable meaningful reduction in the size, complexity and cost of proton therapy systems without compromising clinical utility. Additionally, the company is developing ultra-compact beam delivery solutions – namely beamlines and rotating gantries, taking advantage of the unique properties of laser-accelerated proton beams. Thus HIL aims to deliver, for the first time in history, truly compact, affordable a cost-effective proton therapy systems.

Products and Phases

Product	Phase
Ultra-Compact High-Performance Proton Therapy System	Approved
An ultra-compact, high-performance low-cost laser-proton accelerator and ancillary systems for proton radiation cancer therapy. Proton therapy is the most advanced form of radiotherapy that exists today, to treat cancer; a proton beam is a form of focused radiation used to treat solid tumors. Proton therapy is an established treatment, used routinely around the world and enjoying very high reimbursement; it represents a multi-billion-dollar global opportunity – yet to date less than 5% of this potential is fulfilled due to the extremely large size and high cost of proton therapy systems.

	TARGET MARKETS
	Cancer radiotherapy centers worldwide.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	Hi-Tech Park 4/5, Givat Ram
POB	39011
City	Jerusalem
Country	Israel
Zip	9139000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Sparks, United States

Address	1480 Linda Way
City	Sparks
State/Province	NV
Country	United States
Zip	89431

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Prof. Arie Zigler	Co-Founder
Dr. Shmuel (Shmulik) Eisenmann	Co-Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Third Round

Aug. 01, 2016

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Family Office	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Angel Syndicate	abCDe	Round co-leader
abC Defghij	Services	abCDe	Round co-leader
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Nov. 02, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Family Office	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Angel Syndicate	abCDe
abC Defghij	Private Investor	abCDe

First Round

Oct. 01, 2012

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Nov. 24, 2010

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Technology Transfer Company	abCDe
abC Defghij	Government Agency	abCDe
abC Defghij	Government Agency	abCDe
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jan. 10, 2022

Initial Revenues

abCDe

Co-op with Proton International (Alpharetta, GA).

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-National Fund	abCDe

R&D Grant

Jun. 01, 2021

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 01, 2017

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

	Acquisitions made by HIL Applied Medical

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	Semico...	May. 26, 2016	abCDe

Last Updated:	abCDe
IVC Number:	abCDe